Pfizer Reports $22 Billion Profit on COVID-19 Vaccine, One of Most Profitable Drugs in History

In November 2021, Pfizer reported annual profits of $21.98 billion on revenues of $81.29 billion for 2021, with COVID-19 vaccine sales of $36.7 billion accounting for 45% of total company revenue. The COVID-19 vaccine became one of the most financially successful pharmaceutical products in history, …